LGMD2A

1

Review clinical trials related to LGMD2A. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long-Term Development of Muscular Dystrophy Outcome Assessments

This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).

Participants needed: 1,000
Trial details
Age: 6-50Biological sex: AllType: ObservationalSponsor: Virginia Commonwealth UniversityUpdated: Nov 18, 2025Locations: 1
Eligibility criteria

Age between 6-50 years at enrollment [+3]

Any other illness that would interfere with the ability to undergo safe testing... [+1]